COMMUNIQUÉS West-GlobeNewswire

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
17/02/2026
Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first line (1L) metastatic [...]
Portsmouth Square, Inc. Reports Second Quarter Fiscal 2026 Results; Hotel Performance Improves Year-Over-Year as Market Stabilization Continues
17/02/2026
Los Angeles, California, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (the “Company” or “Portsmouth”) today announced financial results for the fiscal second quarter ended December 31, 2025. Portsmouth’s [...]
HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics
17/02/2026
Announces earnings date and upcoming investor conferences DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account [...]
Genmab Announces Initiation of Share Buy-Back Program
17/02/2026
Company Announcement Repurchase of up to 342,130 shares with a maximum aggregate total value of 725 million DKK Honoring our commitments under the Restricted Stock Unit program Completion expected no later than March 31 [...]
Fortrea renforce son équipe de direction en nommant Oren Cohen au poste de directeur médical et Scott Dove à celui de président des services de pharmacologie clinique
17/02/2026
Cette évolution vient renforcer l’engagement de la direction en faveur du développement clinique précoce et approfondit son partenariat médical et scientifique avec ses clients DURHAM, Caroline du Nord, 17 févr. 2026 ( [...]
Spineway : 2025 annual results
17/02/2026
Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY 2025 annual results Revenue up 4% Improved results Stronger growth potential Condensed consolidated income statement 2025 2024 Pro forma* 2024 Reported In thousands of [...]
SPINEWAY : Résultats annuels 2025
17/02/2026
Ecully, le 17 février 2026 – 18h30 SPINEWAY Résultats annuels 2025 Un chiffre d’affaires en progression de + 4% Une amélioration des résultats Un potentiel de croissance renforcé Compte de résultat consolidé résumé 2025 [...]
Press release: Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
17/02/2026
Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 17, 2026 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
17/02/2026
Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 17 février 2026 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
17/02/2026
Consolidated net revenue of € 2,618.4 million for full year 2025, +11.8% or +8.3% on a like-for-like basis (3) at constant exchange rates (CER) EBITDA (1) of € 991.1 million, +14.5%, margin on net revenue of 37.8% [...]
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
17/02/2026
CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced its participation in World [...]
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
17/02/2026
Media Release COPENHAGEN, Denmark; February 17, 2026 Genmab filed Form 20-F for the financial year 2025 with the U.S. SEC Genmab A/S (Nasdaq: GMAB ) a nnounced today that it has filed its Annual Report for the financial [...]
Genmab Publishes 2025 Annual Report
17/02/2026
Company Announcement COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial [...]
Serotonin Anti-Aging Centers Awards Five-Location Development Agreement for Dallas and Collin County
17/02/2026
Physician-Led Franchise Group Expands Brand’s Presence in the North Texas Market DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers , a national leader in science-backed longevity, hormone [...]
Adagene to Participate in Two Upcoming Investor Conferences
17/02/2026
SAN DIEGO and SUZHOU, China, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today [...]
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices
17/02/2026
Buffalo, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice [...]
JDCA Releases First-of-Its-Kind Report of Companies Working on a Diabetes Cure
17/02/2026
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit focused on accelerating a cure for type 1 diabetes (T1D), announced the release of a comprehensive report of [...]
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
17/02/2026
Access the “What This Means” segment here LA JOLLA, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural [...]
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
17/02/2026
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“ Psyence BioMed ” or the “ Company ”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]

Pages